| Product NDC: | 0093-3002 |
| Proprietary Name: | Quinine Sulfate |
| Non Proprietary Name: | Quinine Sulfate |
| Active Ingredient(s): | 324 mg/1 & nbsp; Quinine Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-3002 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091661 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120928 |
| Package NDC: | 0093-3002-56 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (0093-3002-56) |
| NDC Code | 0093-3002-56 |
| Proprietary Name | Quinine Sulfate |
| Package Description | 30 CAPSULE in 1 BOTTLE (0093-3002-56) |
| Product NDC | 0093-3002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quinine Sulfate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120928 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | QUININE SULFATE |
| Strength Number | 324 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC] |